Follow the strongest findings across the reviewed records
Start with reviewed assessments across organizations, firms, issues, legislation, public officials, changes, and cross-source patterns. Each compact card leads to the profile where its reasoning, alternatives, method, and evidence can be inspected.
This first edition focuses on a selected collection. Lobbying comparisons cover Q1–Q2 2026, while legislation, roles, political-finance records, and federal awards retain their own dates; future editions can add more subjects and periods under the same evidence standards.
Compare where outside firms connect clients, quarters, and disclosed issue categories in the starting network.
AssessmentModerate confidence
Elevate Government Affairs, LLC’s reviewed filing pattern across 2 reviewed clients continued across both quarters, with Copyright/Patent/Trademark recurring.
CPT appears in 4 retained filings across Q1 and Q2; the firm’s profile contains 4 filings and 11 official issue codes.
Cornerstone Government Affairs, Inc.’s reviewed filing pattern across 2 reviewed clients continued across both quarters, with Budget/Appropriations recurring.
BUD appears in 4 retained filings across Q1 and Q2; the firm’s profile contains 4 filings and 4 official issue codes.
Follow how four policy areas are distributed across organizations and reporting periods.
AssessmentModerate confidence
Artificial Intelligence, Technology and Data Privacy filing activity was distributed across 4 reviewed organizations, with no single organization accounting for half of the matches.
62 retained filings matched this issue group. Microsoft had the largest count at 25 (40%), and 4 organizations appeared in both quarters.
Taxes and Government Spending filing activity was distributed across 6 reviewed organizations, with no single organization accounting for half of the matches.
42 retained filings matched this issue group. Microsoft had the largest count at 13 (31%), and 6 organizations appeared in both quarters.
Healthcare, Prescription Drugs and Medicare filing activity was distributed across 4 reviewed organizations, with no single organization accounting for half of the matches.
19 retained filings matched this issue group. Pfizer had the largest count at 8 (42%), and 4 organizations appeared in both quarters.
Read selected bills through their captured procedural position, sponsor record, and carefully bounded context.
AssessmentModerate confidence
HR 3838's captured procedural record reaches one-chamber passage; its role here is legislative context, not evidence of a policy outcome.
As of 2025-09-30, the captured official action history reaches passage in one chamber. Latest recorded action: Received in the Senate. The bill appears in 1 reviewed issue group and has 1 matched sponsor profile plus 1 approved organization subject reference.
HR 9985's captured procedural record reaches referral; its role here is legislative context, not evidence of a policy outcome.
As of 2026-07-30, the captured official action history reaches referral. Latest recorded action: Referred to the House Committee on House Administration. The bill appears in 1 reviewed issue group and has 1 matched sponsor profile.
S 1818's captured procedural record reaches referral; its role here is legislative context, not evidence of a policy outcome.
As of 2025-05-20, the captured official action history reaches referral. Latest recorded action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. The bill appears in 1 reviewed issue group and has 1 matched sponsor profile.
S 4946's captured procedural record reaches referral; its role here is legislative context, not evidence of a policy outcome.
As of 2026-07-13, the captured official action history reaches referral. Latest recorded action: Read twice and referred to the Committee on Commerce, Science, and Transportation. The bill appears in 2 reviewed issue groups and has 1 matched sponsor profile.
Elizabeth Warren's reviewed position combines elected office with a selected committee responsibility in the relevant governmental process.
U.S. Senator for Massachusetts. Ranking Member of Senate Committee on Banking, Housing, and Urban Affairs; Member of Health Care; the selected sponsor record is S 4946.
Period
Selected official records reviewed through 2026-09-05
Ro Khanna's reviewed position combines elected office with a selected committee responsibility in the relevant governmental process.
U.S. Representative for California's 17th Congressional District. Ranking Member of Cyber, Innovative Technologies and Information Systems; the selected sponsor record is HR 9985.
Period
Selected official records reviewed through 2026-09-05
Explore reviewed connections that cross record systems while preserving what each source establishes.
AssessmentModerate confidence
Boeing has a verified institutional footprint across three separate federal record systems in this collection.
The reviewed collection links Boeing to 24 canonical 2026 lobbying filings, an affiliated political committee with a 2024 reporting cycle, and one Department of Defense award record running from 2023-02-28 to 2031-08-30.
Period
Selected records spanning 2023–2031, reviewed through September 2026
The reviewed records form a structural defense-policy connection around H.R. 3838, not evidence of a lobbying outcome.
A contextual edge connects Boeing filing language about the FY2026 defense authorization act to H.R. 3838; a separate verified edge identifies Mike Rogers as the bill sponsor, and an official House record identifies his Armed Services chairmanship.
Gov Influence can use privacy-limited analytics to understand broad site usage. Analytics stays off unless you allow it. Approved custom events exclude questions, search text, email addresses, and political-interest classifications.